Active, not recruiting
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.
NCT05683457
- Conditions
- Cytomegalovirus Infection, Cytomegalovirus Infections, DNA Virus Infections, +8 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Fred Hutchinson Cancer Center Seattle, Washington, United States